abnormal psa referral

abnormal psa referral

20% vs 65%: Slow Referrals Drain Prostate Cancer Budgets

Slow referrals in prostate cancer can push treatment costs into the billions by allowing disease to progress to expensive metastatic stages. A 20% rise in delayed referrals adds roughly $1.2 billion to the U.S. prostate cancer budget each year (The Lancet). Medical Disclaimer: This article is for informational